Meta-analysis of prevention of myocardial infarction by angiotensin converting enzyme inhibitor and angiotensin receptor blocker in relation to change in blood pressure

被引:0
|
作者
Fujisawa, Tomomi [1 ]
Ogihara, Toshio [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Osaka, Japan
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:327 / 327
页数:1
相关论文
共 50 条
  • [1] The Efficacy of Angiotensin Receptor-Neprilysin Inhibitor Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Post Myocardial Infarction: A Meta-Analysis
    Kotak, Sohny
    Hassan, Warda
    Mehmood, Marium
    Kumar, Umesh
    Sagreeka, Fnu
    Karishma, Fnu
    Kumari, Pirya
    Pirya, Fnu
    Saquib, Javeria
    Iqbal, Amna
    Khan, Anosh Aslam
    Varrassi, Giustino
    Khatri, Mahima
    Kumar, Satesh
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [2] Use of an angiotensin converting enzyme inhibitor or angiotensin receptor blocker for the prevention of diabetes mellitus: a meta-analysis.
    Kardas, M
    Gillespie, EL
    White, CM
    Coleman, CI
    [J]. PHARMACOTHERAPY, 2005, 25 (03): : 460 - 460
  • [3] Efficacy and Safety of Angiotensin Receptor-Neprilysin Inhibitor Versus Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker in Acute Myocardial Infarction Patients: A Meta-Analysis of Randomized Controlled Trials
    Ananta, Muammar Emir
    Ivan, Ignatius
    Wijaya, Alya Darin
    Albab, Chabib Fachry
    Danny, Siska
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (16) : S23 - S24
  • [4] Comparative effects of aspirin with angiotensin converting enzyme inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function
    Zhu, BG
    Sievers, RE
    Browne, AE
    Lee, RJ
    Chatterjee, K
    Grossman, W
    Parmley, WW
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 393A - 393A
  • [5] Comparative efficacy of angiotensin converting enzyme inhibitor and angiotensin receptor blocker for patients with acute myocardial infarction and renal dysfunction
    Won, J.
    Jeong, H. K.
    Hong, Y. J.
    Jeong, M. H.
    Kim, Y. J.
    Chae, S. C.
    Hong, T. J.
    Seong, I. W.
    Chae, J. K.
    Kim, C. J.
    Cho, M. C.
    Rha, S. W.
    Bae, J. H.
    Seung, K. B.
    Park, S. J.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 1360 - 1360
  • [6] Comparative Efficacy of Angiotensin Converting Enzyme Inhibitor and Angiotensin Receptor Blocker for Patients With Acute Myocardial Infarction and Renal Dysfunction
    Won, Jumin
    Hong, Young Joon
    Jeong, Myung Ho
    Jeong, Hyung Ki
    Kim, Young Jo
    Chae, Shung Chull
    Hong, Taek Jong
    Seong, In Whan
    Chae, Jei Keon
    Kim, Chong Jin
    Cho, Myeong Chan
    Rha, Seung-Woon
    Bae, Jang Ho
    Seung, Ki Bae
    Park, Seung Jung
    [J]. CIRCULATION, 2017, 136
  • [7] First dose hypotension after angiotensin converting enzyme inhibitor and angiotensin II receptor blocker in patients with acute myocardial infarction
    Spinar, J
    Vitovec, J
    Pluhacek, I
    Spinarova, L
    Fisherova, B
    Toman, J
    [J]. JOURNAL OF HYPERTENSION, 2002, 20 : S211 - S211
  • [8] COMPARABLE LONG-TERM PROGNOSIS AFTER THE CHANGE FROM ANGIOTENSIN-CONVERTING ENZYME INHIBITOR TO ANGIOTENSIN RECEPTOR BLOCKER IN ACUTE MYOCARDIAL INFARCTION
    Kim, H. Y.
    Lim, S. M.
    Chang, K. Y.
    Chung, W. S.
    Seung, K. B.
    [J]. CARDIOLOGY, 2016, 134 : 160 - 160
  • [9] Angiotensin converting enzyme inhibitor or angiotensin II receptor blocker for the prevention of type 2 diabetes mellitus?
    Chen, Ching-Chu
    Chiang, An-Na
    Hsieh, Min-Huang
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 90 (02) : E25 - E26
  • [10] Efficacy and safety of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in diabetic nephropathy: a meta-analysis
    Tian, Mao-Lu
    Shen, Yan
    Sun, Zhao-Lin
    Zha, Yan
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2015, 47 (05) : 815 - 822